Annual EBITDA
-$7.89 M
+$28.03 M+78.03%
December 31, 2023
Summary
- As of February 7, 2025, LFMD annual EBITDA is -$7.89 million, with the most recent change of +$28.03 million (+78.03%) on December 31, 2023.
- During the last 3 years, LFMD annual EBITDA has risen by +$49.53 million (+86.26%).
- LFMD annual EBITDA is now -8550.22% below its all-time high of -$91.20 thousand, reached on December 31, 2015.
Performance
LFMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.13 M
+$1.89 M+47.00%
September 30, 2024
Summary
- As of February 7, 2025, LFMD quarterly EBITDA is -$2.13 million, with the most recent change of +$1.89 million (+47.00%) on September 30, 2024.
- Over the past year, LFMD quarterly EBITDA has increased by +$1.89 million (+47.00%).
- LFMD quarterly EBITDA is now -493.06% below its all-time high of $541.70 thousand, reached on June 30, 2017.
Performance
LFMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$10.12 M
+$705.30 K+6.51%
September 30, 2024
Summary
- As of February 7, 2025, LFMD TTM EBITDA is -$10.12 million, with the most recent change of +$705.30 thousand (+6.51%) on September 30, 2024.
- Over the past year, LFMD TTM EBITDA has increased by +$705.30 thousand (+6.51%).
- LFMD TTM EBITDA is now -64798.08% below its all-time high of -$15.60 thousand, reached on March 31, 2012.
Performance
LFMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LFMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +78.0% | +47.0% | +6.5% |
| 3 y3 years | +86.3% | +84.2% | +81.0% |
| 5 y5 years | -324.1% | +84.2% | +81.0% |
LFMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.2% | -2355.5% | +84.2% | -28.3% | +81.4% |
| 5 y | 5-year | -208.9% | +86.3% | -2355.5% | +93.4% | -296.4% | +87.4% |
| alltime | all time | -8550.2% | +86.3% | -493.1% | +93.4% | <-9999.0% | +87.4% |
LifeMD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.13 M(-47.0%) | -$10.12 M(-6.5%) |
| Jun 2024 | - | -$4.02 M(-1.3%) | -$10.83 M(+6.7%) |
| Mar 2024 | - | -$4.07 M(-4413.6%) | -$10.15 M(+28.7%) |
| Dec 2023 | -$7.89 M(-78.0%) | $94.40 K(-103.3%) | -$7.89 M(-41.2%) |
| Sep 2023 | - | -$2.83 M(-15.2%) | -$13.42 M(-18.7%) |
| Jun 2023 | - | -$3.34 M(+84.8%) | -$16.51 M(-34.4%) |
| Mar 2023 | - | -$1.81 M(-66.7%) | -$25.15 M(-30.0%) |
| Dec 2022 | -$35.92 M(-32.8%) | -$5.43 M(-8.3%) | -$35.92 M(-18.3%) |
| Sep 2022 | - | -$5.93 M(-50.5%) | -$43.98 M(-13.0%) |
| Jun 2022 | - | -$11.98 M(-4.7%) | -$50.53 M(-7.1%) |
| Mar 2022 | - | -$12.58 M(-6.9%) | -$54.38 M(+1.8%) |
| Dec 2021 | -$53.43 M(-6.9%) | -$13.50 M(+8.2%) | -$53.43 M(-25.9%) |
| Sep 2021 | - | -$12.47 M(-21.2%) | -$72.15 M(-9.9%) |
| Jun 2021 | - | -$15.83 M(+36.2%) | -$80.10 M(+18.9%) |
| Mar 2021 | - | -$11.63 M(-63.9%) | -$67.39 M(+17.4%) |
| Dec 2020 | -$57.42 M(+2148.3%) | -$32.22 M(+57.7%) | -$57.42 M(+124.0%) |
| Sep 2020 | - | -$20.42 M(+553.5%) | -$25.64 M(+320.0%) |
| Jun 2020 | - | -$3.13 M(+88.9%) | -$6.10 M(+63.7%) |
| Mar 2020 | - | -$1.65 M(+279.8%) | -$3.73 M(+46.0%) |
| Dec 2019 | -$2.55 M(+37.3%) | -$435.50 K(-51.1%) | -$2.55 M(-7.4%) |
| Sep 2019 | - | -$889.80 K(+18.8%) | -$2.76 M(-0.2%) |
| Jun 2019 | - | -$749.30 K(+56.3%) | -$2.77 M(+5.8%) |
| Mar 2019 | - | -$479.50 K(-25.1%) | -$2.61 M(+8.3%) |
| Dec 2018 | -$1.86 M | -$639.80 K(-28.6%) | -$2.41 M(-9.8%) |
| Sep 2018 | - | -$896.60 K(+50.1%) | -$2.67 M(+10.1%) |
| Jun 2018 | - | -$597.50 K(+113.9%) | -$2.43 M(+88.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$279.30 K(-69.0%) | -$1.29 M(-11.7%) |
| Dec 2017 | -$1.28 M(+8.9%) | -$901.30 K(+38.5%) | -$1.46 M(+15.2%) |
| Sep 2017 | - | -$650.80 K(-220.1%) | -$1.27 M(+53.8%) |
| Jun 2017 | - | $541.70 K(-220.4%) | -$824.30 K(-45.8%) |
| Mar 2017 | - | -$450.00 K(-36.5%) | -$1.52 M(+29.4%) |
| Dec 2016 | -$1.17 M(+1188.0%) | -$708.30 K(+241.0%) | -$1.17 M(+92.6%) |
| Sep 2016 | - | -$207.70 K(+35.2%) | -$610.00 K(+65.3%) |
| Jun 2016 | - | -$153.60 K(+46.1%) | -$369.10 K(+69.0%) |
| Mar 2016 | - | -$105.10 K(-26.8%) | -$218.40 K(+139.5%) |
| Dec 2015 | -$91.20 K(-78.1%) | -$143.60 K(-532.5%) | -$91.20 K(+16.5%) |
| Sep 2015 | - | $33.20 K(-1244.8%) | -$78.30 K(-61.8%) |
| Jun 2015 | - | -$2900.00(-113.1%) | -$205.20 K(-22.1%) |
| Mar 2015 | - | $22.10 K(-116.9%) | -$263.40 K(-36.7%) |
| Dec 2014 | -$416.00 K(+84.8%) | -$130.70 K(+39.5%) | -$416.00 K(+21.1%) |
| Sep 2014 | - | -$93.70 K(+53.4%) | -$343.50 K(-9.4%) |
| Jun 2014 | - | -$61.10 K(-53.2%) | -$379.20 K(+17.0%) |
| Mar 2014 | - | -$130.50 K(+124.2%) | -$324.00 K(+44.0%) |
| Dec 2013 | -$225.10 K(-44.1%) | -$58.20 K(-55.0%) | -$225.00 K(-1.2%) |
| Sep 2013 | - | -$129.40 K(+2093.2%) | -$227.70 K(-8.1%) |
| Jun 2013 | - | -$5900.00(-81.3%) | -$247.80 K(-40.8%) |
| Mar 2013 | - | -$31.50 K(-48.3%) | -$418.40 K(+4.0%) |
| Dec 2012 | -$402.50 K(-9.0%) | -$60.90 K(-59.3%) | -$402.50 K(+17.8%) |
| Sep 2012 | - | -$149.50 K(-15.3%) | -$341.60 K(+77.8%) |
| Jun 2012 | - | -$176.50 K(+1031.4%) | -$192.10 K(+1131.4%) |
| Mar 2012 | - | -$15.60 K | -$15.60 K |
| Dec 2011 | -$442.20 K | - | - |
FAQ
- What is LifeMD annual EBITDA?
- What is the all time high annual EBITDA for LifeMD?
- What is LifeMD annual EBITDA year-on-year change?
- What is LifeMD quarterly EBITDA?
- What is the all time high quarterly EBITDA for LifeMD?
- What is LifeMD quarterly EBITDA year-on-year change?
- What is LifeMD TTM EBITDA?
- What is the all time high TTM EBITDA for LifeMD?
- What is LifeMD TTM EBITDA year-on-year change?
What is LifeMD annual EBITDA?
The current annual EBITDA of LFMD is -$7.89 M
What is the all time high annual EBITDA for LifeMD?
LifeMD all-time high annual EBITDA is -$91.20 K
What is LifeMD annual EBITDA year-on-year change?
Over the past year, LFMD annual EBITDA has changed by +$28.03 M (+78.03%)
What is LifeMD quarterly EBITDA?
The current quarterly EBITDA of LFMD is -$2.13 M
What is the all time high quarterly EBITDA for LifeMD?
LifeMD all-time high quarterly EBITDA is $541.70 K
What is LifeMD quarterly EBITDA year-on-year change?
Over the past year, LFMD quarterly EBITDA has changed by +$1.89 M (+47.00%)
What is LifeMD TTM EBITDA?
The current TTM EBITDA of LFMD is -$10.12 M
What is the all time high TTM EBITDA for LifeMD?
LifeMD all-time high TTM EBITDA is -$15.60 K
What is LifeMD TTM EBITDA year-on-year change?
Over the past year, LFMD TTM EBITDA has changed by +$705.30 K (+6.51%)